
The EU fine-tunes the Falsified Medicines Directive.

The EU fine-tunes the Falsified Medicines Directive.

The European Medicines Agency has added granularity to its biosimilars approval pathway by releasing a guideline on mAbs.

The government of Turkey is drawing up a program in coordination with the pharmaceutical industry to create ways to make the country a regional production center for pharmaceuticals serving Europe, Central Asia, and the Middle East.